Clovis Oncology, Inc. Skyrocketed
Fri, Mar 19, 2021 at 05:30 PM
Clovis Oncology, Inc. (CLVS:NASDAQ) jumped higher at $7.86, representing a gain of 47.7%. On Thu 18 Mar 21, CLVS:NASDAQ touched a New 2-Week Low of $5.32. The stock got featured on our News Catalysts scanner on Fri 19 Mar 21 at 02:08 PM in the 'BIOTECH' category. From Thu 04 Mar 21, the stock recorded 30.00% Up Days and 36.36% Green Days
The stock spiked on Mon 08 Feb 21 at $11.1 with a volume of 19M+, and its share price has been moving sideways in recent weeks.
About Clovis Oncology, Inc. (CLVS:NASDAQ)
Clovis Oncology Inc is a biopharmaceutical company focused on acquiring, developing and commercializing cancer treatments in the United States, Europe and other international markets.
Top 10 Gainers:
- SuperCom Ltd. (SPCB:NASDAQ), 54.48%
- Clovis Oncology, Inc. (CLVS:NASDAQ), 47.74%
- HOFV (HOFV:NASDAQ), 46.52%
- FHTX (FHTX:NASDAQ), 36.61%
- SenesTech, Inc. (SNES:NASDAQ), 35.12%
- Marker Therapeutics, Inc. (MRKR:NASDAQ), 34.44%
- Till Capital Ltd. (TIL:NASDAQ), 32.2%
- StoneMor Inc. (STON:NYSE), 32.04%
- Adams Resources & Energy, Inc. (AE:NYSEMKT), 27.82%
- Euroseas Ltd. (ESEA:NASDAQ), 27.77%